Michael Aboud
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 24
- HIV/AIDS Research and Interventions 5
- Tuberculosis Research and Epidemiology 1
- Virology 9
- HIV Research and Treatment 9
- Co-authors
- Brian Wynne (13 shared papers)Martin Gartland (9 shared papers)Mark Underwood (8 shared papers)Kimberly Y. Smith (11 shared papers)Lesley Kahl (4 shared papers)Kati Vandermeulen (4 shared papers)Cynthia Brinson (2 shared papers)Elizabeth A. Blair (3 shared papers)
- Journals
- Open Forum Infectious Diseases (4 papers)Antiviral Therapy (4 papers)Journal of Infection and Public Health (3 papers)Journal of the International AIDS Society (2 papers)Therapeutic Advances in Drug Safety (2 papers)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Michael Aboud
32 papers receiving 1.1k citations
Michael Aboud's Hit Papers
Peers
Comparison fields: 5 of 57
- Virology 343
- Infectious Diseases 815
- Emergency Medicine 317
- Epidemiology 86
- Hepatology 19
Countries citing papers authored by Michael Aboud
This map shows the geographic impact of Michael Aboud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Aboud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Aboud more than expected).
Fields of papers citing papers by Michael Aboud
This network shows the impact of papers produced by Michael Aboud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Aboud. The network helps show where Michael Aboud may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Aboud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies Hit paper breakdown → | 2018 | 246 |
| 2 | 2020 | 178 | |
| 3 | 2019 | 106 | |
| 4 | 2016 | 84 | |
| 5 | 2022 | 81 | |
| 6 | 2019 | 78 | |
| 7 | 2016 | 76 | |
| 8 | 2007 | 52 | |
| 9 | 2010 | 45 | |
| 10 | 2017 | 43 | |
| 11 | 2010 | 20 | |
| 12 | 2020 | 15 | |
| 13 | 2018 | 13 | |
| 14 | 2016 | 11 | |
| 15 | 2015 | 9 | |
| 16 | 2018 | 7 | |
| 17 | 2019 | 7 | |
| 18 | 2021 | 7 | |
| 19 | 2020 | 6 | |
| 20 | 2019 | 5 |
About Michael Aboud
Michael Aboud is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Epidemiology and Oncology, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (24 papers), HIV Research and Treatment (9 papers), HIV-related health complications and treatments (8 papers), HIV/AIDS Research and Interventions (5 papers), Hepatitis C virus research (2 papers), Lymphatic System and Diseases (2 papers), Chronic Lymphocytic Leukemia Research (1 paper) and Tuberculosis Research and Epidemiology (1 paper). The work is most often cited by research in Virology (343 citations), Infectious Diseases (815 citations), Emergency Medicine (317 citations), Epidemiology (86 citations) and Hepatology (19 citations). Michael Aboud has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Brian Wynne, Martin Gartland, Mark Underwood, Kimberly Y. Smith, Lesley Kahl, Kati Vandermeulen, Cynthia Brinson, Elizabeth A. Blair, Ranjababu Kulasegaram and Ali Elgalib. Their work appears in journals such as Open Forum Infectious Diseases, Antiviral Therapy, Journal of Infection and Public Health, Journal of the International AIDS Society and Therapeutic Advances in Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.